Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension

por Richeldi, Luca, Kreuter, Michael, Selman, Moisés, Crestani, Bruno, Kirsten, Anne-Marie, Wuyts, Wim A, Xu, Zuojun, Bernois, Katell, Stowasser, Susanne, Quaresma, Manuel, Costabel, Ulrich
Publicado 2018